ArticleFrontiers in immunology2026
Survival outcomes of intensity-modulated radiotherapy combined with immunotherapy and targeted therapy for hepatocellular carcinoma with classification I-IV portal vein tumor thrombus: a propensity score matching study.
Lijun Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.